Subscribe
|
Contact Us
|
CardioDx Raises Strategic Venture Capital
Monday, May 17, 2010
5:38:00 AM PDT | VentureDeal Staff
Palo Alto, California -- Medical device company
CardioDx
has secured $5 million in additional strategic venture capital.
CardioDx is developing genomic tests to help tailor individualized care for people with cardiovascular diseases.
GE Healthymagination Fund made the investment as part of the fourth round of company funding. Proceeds purposes from the financing were not disclosed.
Email Page
|
Print Page
Loading
Want unlimited access to the
complete database
with thousands of technology companies, VCs and transactions for only $25 per month?
Start your
Free 14 Day Trial
now – no obligation or credit card required.
